Clinical Trials and Validation in Femtech: Attracting Participants and Funding

The femtech industry stands at a critical juncture as it works to establish scientific credibility and clinical validation for innovative solutions in women's health. Traditional clinical trial models often fall short in addressing the unique challenges of testing femtech products, from recruitment strategies to study design and outcome measurements. Meanwhile, funding disparities continue to impact the ability to conduct robust clinical research, despite the growing market potential of women's health technologies.

Innovative approaches to clinical validation are emerging, combining rigorous scientific methodology with practical considerations unique to women's health technology. Forward-thinking organizations are exploring novel participant engagement strategies, alternative funding models, and adaptive trial designs that better align with both regulatory requirements and the real-world application of femtech solutions.

Join us to discuss:

1. What innovative approaches to clinical trial design and recruitment are proving successful in the femtech space?
2. How are leading femtech companies balancing the need for scientific validation with the pressures of market development and investor expectations?
3. Which strategies are most effective in securing funding for clinical trials in women's health technology, and what role do different stakeholders play?